Accendra Health Inc 's Revenue in the fiscal year 2025 $ 2,762.03 millions
Accendra Health Inc 's Revenue in the fiscal year 2022 $ 42,189.29 millions
Accendra Health Inc 's Revenue in the fiscal year 2021 $ 42,329.38 millions
Accendra Health Inc 's Revenue in the fiscal year 2020 $ 28,504.87 millions
Accendra Health Inc 's Revenue in the fiscal year 2019 $ 27,302.45 millions
ACH Revenue first quarter 2026 Y/Y Growth Comment
Accendra Health Inc reported drop in Revenue in the first quarter 2026 by -74.89% to $ 627.78 millions, from the same quarter in 2025. The fall in the first quarter 2026 Accendra Health Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 228.14%.
According to the results reported in the first quarter 2026, Accendra Health Inc achieved the best Revenue growth in Aluminum industry. While Accendra Health Inc ' s Revenue meltdown of -74.89% ranks overall at the positon no. 261 in the first quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Accendra Health Inc 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
1591.7 %
237.2 %
-100 %
(Dec 31 2021)
ACH's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2026 Accendra Health Inc disclosed drop in Revenue from the fourth quarter by -11.45% to $ 627.78 millions, from $ 708.97 millions achived in the previous reporting period.
Although periodic circumstance commonly energize I. Quarter 2026 Revenue, this plainly could not be substantial to rescue Aluminum's company achievement, Most analysts pointed out.
Within Aluminum industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Accendra Health Inc 's Revenue growth quarter on quarter, overall rank is 2959.
In the I. Quarter 2026 Accendra Health Inc disclosed drop in Revenue from the fourth quarter by -11.45% to $ 627.78 millions, from $ 708.97 millions achived in the previous reporting period.
Although periodic circumstance commonly energize I. Quarter 2026 Revenue, this plainly could not be substantial to rescue Aluminum's company achievement, Most analysts pointed out.
Within Aluminum industry 2 other companies have achieved higher Revenue quarter on quarter growth. While Accendra Health Inc 's Revenue growth quarter on quarter, overall rank is 2959.
Accendra Health Inc 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Dec 31 2022)
12 Months Ending 0
12 Months Ending 0
Cumulative Revenue 12 Months Ending
$ 0.00
$ 0.00
$ 49,593.65
$ 49,733.75
$ 49,738.53
Y / Y Revenue Growth (TTM)
-
-
-0.11 %
38.83 %
40.07 %
Year on Year Revenue Growth Overall
Ranking
# 261
# 58
# 31
# 0
# 0
Seqeuential Revenue Change (TTM)
-
-
-0.28 %
-0.01 %
0.02 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2487
# 58
# 31
# 0
# 0
Cumulative Revenue growth Comment
In the Mar 31 2026 period, Accendra Health Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.
Among companies within the Basic Materials sector 18 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 58 to 261.
In the Mar 31 2026 period, Accendra Health Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.
Among companies within the Basic Materials sector 18 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 58 to 261.
About Accendra Health Inc Revenue Growth Rates (ACH), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
What’s included here
Company: Aluminum Corp Of China Ltd
(CIK 1161611).
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.